LINCOLN, NEBRASKA (RFD NEWS) — A new vaccine is showing promise in combating Highly Pathogenic Avian Influenza (HPAI), with testing currently underway in mice and dairy calves. The promising research is led by the University of Nebraska–Lincoln (UNL).
UNL Professor of Biological Sciences Eric Weaver joined us on Tuesday’s Market Day Report to provide an update on the development.
In his interview with RFD News, Weaver discussed details of the vaccine and the results from early testing. He also outlined the next steps in the research process as work continues.
Finally, Weaver explained the potential impacts this vaccine could have on the livestock industry as it continues to battle HPAI.
Related Stories
Declining cases prompt officials to ease nationwide poultry restrictions, though local measures remain available if needed.
$2 million project tests fogging system to stop the virus in poultry facilities
More than 15 million birds were affected by bird flu, but fewer outbreaks are helping bring egg prices down
Bigger flocks are rebuilding egg and poultry supply.
As spring migration ramps up, USDA officials warn farmers about rising bird flu risks and urge stronger biosecurity measures. Resources are available through APHIS to help protect livestock.
APHIS Veterinary Medical Officer Dr. Chelsey Shiveley discusses USDA’s biosecurity resources available to poultry producers ahead of spring migration, increasing the risk of Highly Pathogenic Avian Influenza (HPAI) threatens commercial flocks.
